These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2932058)

  • 21. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical trial of 5'-DFUR against various malignant tumors].
    Okumura T
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
    Iigo M; Miwa M; De Clercq E
    Jpn J Cancer Res; 1990 Apr; 81(4):431-5. PubMed ID: 2142152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusion.
    Reece PA; Olver IN; Morris RG; Bishop JF; Guentert TW; Hill HS; Hillcoat BL
    Cancer Chemother Pharmacol; 1990; 25(4):274-8. PubMed ID: 2136810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [TUT-7 phase I clinical study. TUT-7 Study Group].
    Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1125-33. PubMed ID: 9239166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
    Fukuoka M; Miyazaki T; Yoshida Y; Hattori M; Niitani H; Nakamura T; Hirota Y; Ohta K; Tanaka M; Suzuoki Y
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Hoshino A; Ohara K; Kamiya O; Nagata K; Ono Y; Kawakubo A; Ozaki Y; Suzuki A; Ogasawara T; Sugiura I
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1079-82. PubMed ID: 2938548
    [No Abstract]   [Full Text] [Related]  

  • 32. [Phase I clinical study of a new fluorinated pyrimidine antineoplastic agent, TAC-278].
    Koyama Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):443-56. PubMed ID: 7184408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of N-methylformamide.
    McVie JG; ten Bokkel Huinink WW; Simonetti G; Dubbelman R
    Cancer Treat Rep; 1984 Apr; 68(4):607-10. PubMed ID: 6325001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase I study of raltitrexed (ZD-1694)].
    Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2075-84. PubMed ID: 9838910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phase II study of FF-705 by Clinical Cooperative Study Group].
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):150-6. PubMed ID: 6230055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [5-fluorouracil concentration in gastroenterological tumor tissues, in adjacent normal tissues, and in serum after preoperative oral administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nozue M; Todoroki T; Ueda H; Fukuda S; Miyamoto H; Kawai Y; Iwasaki Y
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):377-82. PubMed ID: 1825909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
    Iigo M; Nakajima Y; Araki E; Hoshi A
    Jpn J Cancer Res; 1989 Feb; 80(2):182-7. PubMed ID: 2524459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
    Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
    Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
    Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer].
    Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.